Histone acetyltransferase HBO1 inhibits NF-κB activity by coactivator sequestration

Biochemical and Biophysical Research Communications

Volumn 350, Issue 1, 2006, Pages 208-213

  Contzler, Romuald ^a   Regamey, Alexander ^a   Favre, Bertrand ^a   Roger, Thierry ^a   Hohl, Daniel ^a   Huber, Marcel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Coactivators; Gene regulation; Histone acetyltransferase

Indexed keywords

DNA; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE HBO1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERINE; SYNAPTOTAGMIN; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL PROCESSING;

CELL LINE; HISTONE ACETYLTRANSFERASES; HUMANS; NF-KAPPA B; RECEPTORS, ANDROGEN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749064383     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.030     Document Type: Article

References (20)

1. Hayden M.S., and Gosh S. Signaling to NF-KB. Gene. Dev. 18 (2004) 2195-2224
2. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25 (2004) 280-288
3. Chen L.F., and Greene W.C. Shaping the nuclear action of NF-KB. Nat. Rev. Mol. Cell Biol. 5 (2004) 392-401
4. Iizuka M., and Stillman B. Histone acetyltransferase HBO1 interacts with the ORC1 subunit of the human initiator protein. J. Biol. Chem. 274 (1999) 23027-23034
5. Burke T.W., Cook J.G., Asano M., and Nevins J.R. Replication factors MCM2 and ORC1 interact with the histone acetyltransferase HBO1. J. Biol. Chem. 276 (2001) 15397-15408
6. Sharma M., Zarnegar M., Li X., Lim B., and Sun Z. Androgen receptor interacts with a novel MYST protein, HBO1. J. Biol. Chem. 275 (2000) 35200-35208
7. Georgiakaki M., Chabbert-Buffet N., Dasen B., Meduri G., Wenk S., Rajhi L., Amazit L., Chauchereau A., Burger C.W., Blok L.J., Milgrom E., Lombes M., Guiochon-Mantel A., and Loosfelt H. Ligand-controlled interaction of HBO1 with the N-terminal transactivating domain of progesterone receptor induces SRC-1 dependent co-activation of transcription. Mol. Endocrinol. 20 (2006) 2122-2140
8. Zong H., Li Z., Liu L., Hong Y., Yun X., Jiang J., Chi Y., Wang H., Shen X., Hu Y., Niu Z., and Gu J. Cyclin-dependent kinase 11(p58) interacts with HBO1 and enhances its histone acetyltransferase activity. FEBS Lett. 579 (2005) 3579-3588
9. Doyon Y., Cayrou C., Ullah M., Landry A.J., Cote V., Selleck W., Lane W.S., Tan S., Yang X.J., and Cote J. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol. Cell 21 (2006) 51-64
10. Cinar B., Yeung F., Konaka H., Mayo M.W., Freeman M.R., Zhau H.E., and Chung L.W. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells. Biochem. J. 379 (2004) 421-431
11. Palvimo J.J., Reinikainen P., Ikonen T., Kallio P.J., Moilanen A., and Janne O.A. Mutual transcriptional interference between RelA and androgen receptor. J. Biol. Chem. 271 (1996) 24151-24156
12. Verrijdt G., Schoenmakers E., Haelens A., Peeters B., Verhoeven G., Rombauts W., and Claessens F. Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J. Biol. Chem. 275 (2000) 12298-12305
13. Roger T., David J., Glauser M.P., and Calandra T. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414 (2001) 920-924
14. Roger T., Out T., Mukaida N., Matsushima K., Jansen H., and Lutter R. Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells. Biochem. J. 330 (1998) 429-435
15. Utley R.T., and Cote J. The MYST family of histone acetyltransferases. Curr. Top. Microbiol. Immunol. 274 (2003) 203-236
16. Berkovits-Cymet H.J., Amann B.T., and Berg J.M. Solution structure of a CCHHC domain of neural zinc finger factor-1 and its implications for DNA binding. Biochemistry 43 (2004) 898-903
17. Linding R., Jensen L.J., Diella F., Bork P., Gibson T.J., and Russell R.B. Protein disorder prediction: implications for structural proteomics. Structure 11 (2003) 1453-1459
18. Iakoucheva L.M., and Dunker A.K. Order, disorder, and flexibility: prediction from protein sequence. Structure 11 (2003) 1316-1317
19. Owen H.R., Quadroni M., Bienvenut W., Buerki C., and Hottiger M.O. Identification of novel and cell type enriched cofactors of the transcription activation domain of RelA (p65 NF-kappaB). J. Proteome Res. 4 (2005) 1381-1390
20. Clark J., Edwards S., John M., Flohr P., Gordon T., Maillard K., Giddings I., Brown C., Bagherzadeh A., Campbell C., Shipley J., Wooster R., and Cooper C.S. Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Gene. Chromosome. Canc. 34 (2002) 104-114